已收盘 05-15 16:00:00 美东时间
-4.560
-18.49%
光通信行情彻底爆发!2倍做多POET大涨逾52%,2倍做多应用光电升超48%;纳微半导体绩后大涨超24%,带动2倍做多纳微半导体ETF涨近50%;银价隔夜大涨超7%,2倍做多白银ETF涨超14%>>
05-12 17:49
存储热潮进入“抛物线”式上涨!两倍做多美光ETF狂飙超83%,两倍做多闪迪ETF涨超67%;冲刺7900点!机构上调标普500年底目标价,看好AI行业前景>>
05-09 17:41
Leverage Shares每日2倍做多IREN主动型ETF涨21.17%,报28.91美元
05-08 09:01
Leverage Shares每日2倍做多IREN主动型ETF涨17.27%,报27.98美元
05-08 08:41
Leverage Shares每日2倍做多IREN主动型ETF涨14.29%,报27.27美元
05-08 08:00
Dr. Morrissey continued: "Our R&D organization is on track to deliver multiple milestones this year across our zanzalintinib pivotal development program. We expect key data readouts from STELLAR-303 and STELLAR-304,
05-06 05:49
Leverage Shares每日2倍做多IREN主动型ETF涨13.23%,报16.0美元
05-01 12:23
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LITESPARK-012 trial evaluating combination regimens for the first-line treatment of patients with
04-21 18:47
Leverage Shares每日2倍做多IREN主动型ETF跌12.33%,报10.97美元
04-13 08:00
Leverage Shares每日2倍做多IREN主动型ETF涨15.85%,报11.99美元
04-08 12:24